Patents by Inventor C. Hodges

C. Hodges has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5612002
    Abstract: A method for the multiple, simultaneous synthesis of compounds comprising the steps of: 1) providing an apparatus comprising a plurality of reaction tubes having filter members on their lower ends, a reservoir member for receiving the filter member, a holder member having a plurality of apertures for supporting the reaction tubes, and a manifold member adjacent to the holder member and enclosing the upper ends of the reaction tubes; 2) charging the apparatus with reactants required for synthesis; 3) synthesizing the compounds in solution; or optionally 4) cleaving the compounds from a solid support within the apparatus.
    Type: Grant
    Filed: April 28, 1995
    Date of Patent: March 18, 1997
    Assignee: Warner-Lambert Company
    Inventors: Donna R. Cody, Sheila H. H. DeWitt, John C. Hodges, John S. Kiely, Walter H. Moos, Michael R. Pavia, Bruce D. Roth, Mel C. Schroeder, Charles J. Stankovic
  • Patent number: 5571792
    Abstract: Novel inhibitors of protein farnesyltransferase enzyme are described, as well as methods for the preparation and pharmaceutical compositions of the same, which are useful in controlling tissue proliferative diseases, including cancer and restenosis.
    Type: Grant
    Filed: June 30, 1994
    Date of Patent: November 5, 1996
    Assignee: Warner-Lambert Company
    Inventors: Gary L. Bolton, John C. Hodges, Michael W. Wilson
  • Patent number: 5538751
    Abstract: A thickened foodstuff having improved storage stability and retention of smoothness upon reheating which contains a non-pre-gelatinized amylose polymer containing component and a second biopolymer selected from the group consisting of a sheared amylopectin component, iota carrageenan, kappa carrageenan, xanthan, maltodextrins, pectins, alginates, agar, gum arabic, locust bean gum, guar gum, carboxymethyl cellulose, hydroxy propyl methyl cellulose, and mixtures thereof; with the amylose polymer containing component present as a dispersed phase.
    Type: Grant
    Filed: November 1, 1994
    Date of Patent: July 23, 1996
    Assignee: Unilever Patent Holdings B.V.
    Inventors: Jeremy B. Carter, Joanne M. Brown, Rosalind C. Hodges, Ingrid A. Appelqvist, Charles R. Brown, Isan T. Norton
  • Patent number: 5525614
    Abstract: This invention relates to novel substituted 1,2,3,4-tetrahydroisoquinolines which are useful in the treatment of vascular restenosis, various disorders of the central nervous system, in the regulation of female reproductive functions, in cognitive enhancement, in atherosclerosis and in treating excessive AVP secretory disorders. Novel intermediates useful in the preparation of the compounds are also disclosed. Methods of using the compounds and pharmaceutical compositions containing them are disclosed.
    Type: Grant
    Filed: July 31, 1995
    Date of Patent: June 11, 1996
    Assignee: Warner-Lambert Company
    Inventors: Clifton J. Blankley, John C. Hodges, Sylvester Klutchko
  • Patent number: 5515966
    Abstract: A carton for holding a variety of products characterized by improved closure construction and display characterized by a back panel with a pair of side panels attached thereto, including a bottom portion for holding a product in place and further characterized by a strap located above the lower front panel adapted to traverse the contained product and latched on the back of the carton to hold the product in place for display and sale.
    Type: Grant
    Filed: April 20, 1994
    Date of Patent: May 14, 1996
    Inventors: Donald C. Hodge, Melanie B. Hodge, Kathryn A. Powell
  • Patent number: 5489686
    Abstract: This invention relates to novel substituted 1,2,3,4-tetrahydroisoquinolines which are useful in the treatment of vascular restenosis, various disorders of the central nervous system, in the regulation of female reproductive functions, in cognitive enhancement, in atherosclerosis and in treating excessive AVP secretory disorders. Novel intermediates useful in the preparation of the compounds are also disclosed. Methods of using the compounds and pharmaceutical compositions containing them are disclosed.
    Type: Grant
    Filed: April 28, 1994
    Date of Patent: February 6, 1996
    Assignee: Warner-Lambert Company
    Inventors: Clifton J. Blankley, John C. Hodges, Sylvester Klutchko
  • Patent number: 5444069
    Abstract: The present invention relates to the use of 4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine-6-carboxylic acids and analogs thereof in antagonizing the binding of angiotensin II to AT.sub.2 receptors to treat memory loss.
    Type: Grant
    Filed: April 13, 1994
    Date of Patent: August 22, 1995
    Assignee: Warner-Lambert Company
    Inventors: David T. Dudley, John C. Hodges, Thomas A. Pugsley, Michael D. Taylor
  • Patent number: 5436260
    Abstract: Substituted 1-benzylimidazole-5-methylidene hydantoins are disclosed as well as methods of preparing them, pharmaceutical compositions containing them, and methods of using them. Intermediates useful in the preparation of the compounds of the invention are also disclosed and synthetic methods for preparing the novel intermediates. The compounds are useful as antagonists of angiotensin II and thus are useful in the control of hypertension, hyperaldosteronism, congestive heart failure, surgically induced vascular smooth muscle proliferation, and glaucoma.
    Type: Grant
    Filed: January 4, 1994
    Date of Patent: July 25, 1995
    Assignee: Warner-Lambert Company
    Inventors: John C. Hodges, Sylvester Klutchko
  • Patent number: 5350757
    Abstract: This invention relates to novel substituted 1,2,3,4-tetrahydroisoquinolines which are useful the treatment of vascular restenosis, various disorders of the central nervous system, in the regulation of female reproductive functions, in cognitive enhancement, in atherosclerosis and in treating excessive AVP secretory disorders. Novel intermediates useful in the preparation of the compounds are also disclosed. Methods of using the compounds and pharmaceutical compositions containing them are disclosed.
    Type: Grant
    Filed: June 11, 1993
    Date of Patent: September 27, 1994
    Assignee: Warner-Lambert Company
    Inventors: Clifton J. Blankley, John C. Hodges, Sylvester Klutchko
  • Patent number: 5338744
    Abstract: The present invention relates to the use of 4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine-6-carboxylic acids and analogs thereof in antagonizing the binding of angiotensin II to AT.sub.2 receptors.
    Type: Grant
    Filed: August 19, 1992
    Date of Patent: August 16, 1994
    Assignee: Warner-Lambert Company
    Inventors: David T. Dudley, John C. Hodges, Thomas A. Pugsley, Michael D. Taylor
  • Patent number: 5324483
    Abstract: An apparatus and method which provides a suitable location for multiple, simultaneous synthesis of compounds. The apparatus consists of: a reservoir block having a plurality of wells; a plurality of reaction tubes, usually gas dispersion tubes, having filters on their lower ends; a holder block, having a plurality of apertures; and a manifold, which may have ports to allow introduction/maintenance of a controlled environment. The manifold top wall has apertures and a detachable plate with identical apertures. The apparatus is constructed from materials which will accommodate heating, cooling, agitation, or corrosive reagents. Gaskets are placed between the components. Rods or clamps are provided for fastening the components together. Apparatus operation involves placing the filters on the lower ends of the reaction tubes in the reservoir block wells, and the upper ends passing through the holder block apertures and into the manifold.
    Type: Grant
    Filed: February 2, 1993
    Date of Patent: June 28, 1994
    Assignee: Warner-Lambert Company
    Inventors: Donna R. Cody, Sheila H. H. DeWitt, John C. Hodges, John S. Kiely, Walter H. Moos, Michael R. Pavia, Bruce D. Roth, Mel C. Schroeder, Charles J. Stankovic
  • Patent number: 5308853
    Abstract: Substituted 1-benzylimidazole-5-methylidene hydantoins are disclosed as well as methods of preparing them, pharmaceutical compositions containing them, and method of using them. Intermediates useful in the preparation of the compounds of the invention are also disclosed and synthetic methods for preparing the novel intermediates. The compounds are useful as antagonists of angiotensin II and thus are useful in the control of hypertension, hyperaldosteronism, congestive heart failure, surgically induced vascular smooth muscle proliferation, and glaucoma.
    Type: Grant
    Filed: November 19, 1992
    Date of Patent: May 3, 1994
    Assignee: Warner-Lambert Company
    Inventors: John C. Hodges, Sylvester Klutchko
  • Patent number: 5288851
    Abstract: The invention concerns novel renin-inhibitory peptides which are useful for treating renin-associated hypertension, congestive heart failure, hyperaldosteronism and diseases caused by retroviruses including HTLV-I and -III. Processes for preparing the peptides, novel intermediates useful in the preparation thereof, compositions containing them, and methods of using them are included. Also included is a diagnostic method which uses the compounds to determine the presence of renin-associated hypertension, congestive heart failure, or hyperaldosteronism.
    Type: Grant
    Filed: August 4, 1992
    Date of Patent: February 22, 1994
    Assignee: Warner-Lambert Company
    Inventors: Annette M. Doherty, Harriet W. Hamilton, John C. Hodges, Joseph T. Repine, Ila Sircar
  • Patent number: 5276048
    Abstract: Novel substituted 4-(1-H-pyrrol-1-yl)imidazoles are disclosed as well as methods of preparing them, pharmaceutical compositions containing them, and methods of using them. Novel intermediates useful in the preparation of the compounds of the invention are also disclosed and synthetic methods for preparing the novel intermediates. The compounds are useful as antagonists of angiotensin II and thus are useful in the control of hypertension, hyperaldosteronism, congestive heart failure, glaucoma, vascular smooth muscle proliferation associated with atherosclerosis, and with postsurgical vascular restenosis.
    Type: Grant
    Filed: October 13, 1992
    Date of Patent: January 4, 1994
    Assignee: Warner-Lambert Company
    Inventors: John C. Hodges, John G. Topliss
  • Patent number: 5260278
    Abstract: The invention concerns novel renin-inhibitory peptides which are useful for treating renin-associated hypertension, congestive heart failure, hyperaldosteronism, and diseases caused by retroviruses including HTLV-I and -III. Processes for preparing the peptides, compositions containing them, and methods of using them are included. Also included is a diagnostic method which uses the compounds to determine the presence of renin-associated hypertension, or hyperaldosteronism.
    Type: Grant
    Filed: April 1, 1991
    Date of Patent: November 9, 1993
    Assignee: Warner-Lambert Company
    Inventors: Richard Himmelsbach, John C. Hodges, James S. Kaltenbronn, William C. Patt, Joseph T. Repine, Ila Sircar
  • Patent number: 5246943
    Abstract: This invention relates to novel substituted 1,2,3,4-tetrahydroisoquinolines which are useful in the treatment of vascular restenosis, various disorders of the central nervous system, in the regulation of female reproductive functions, in cognitive enhancement, in atherosclerosis and in treating excessive AVP secretory disorders. Novel intermediates useful in the preparation of the compounds are also disclosed. Methods of using the compounds and pharmaceutical compositions containing them are disclosed.
    Type: Grant
    Filed: May 19, 1992
    Date of Patent: September 21, 1993
    Assignee: Warner-Lambert Company
    Inventors: Clifton J. Blankley, John C. Hodges, Sylvester Klutchko
  • Patent number: 5210211
    Abstract: Novel substituted 4-(1-H-pyrrol-1-yl)imidazoles are disclosed as well as methods of preparing them, pharmaceutical compositions containing them, and methods of using them. Novel intermediates useful in the preparation of the compounds of the invention are also disclosed and synthetic methods for preparing the novel intermediates. The compounds are useful as antagonists of angiotensin II and thus are useful in the control of hypertension, hyperaldosteronism, congestive heart failure, glaucoma, vascular smooth muscle proliferation associated with atherosclerosis, and with postsurgical vascular restenosis.
    Type: Grant
    Filed: May 19, 1992
    Date of Patent: May 11, 1993
    Assignee: Warner-Lambert Company
    Inventors: John C. Hodges, John G. Topliss
  • Patent number: 5198426
    Abstract: The invention concerns novel renin-inhibitory peptides which are useful for treating renin-associated hypertension, congestive heart failure, hyperaldosteronism, glaucoma and diseases caused by retroviruses. Processes for preparing the peptides novel intermediates in the processes, compositions containing them, and methods of using them are included. Also included is a diagnostic method which uses the compounds to determine the presence of renin-associated hypertension, or hyperaldosteronism.
    Type: Grant
    Filed: December 4, 1989
    Date of Patent: March 30, 1993
    Assignee: Warner-Lambert Company
    Inventors: James M. Hamby, John C. Hodges, Sylvester Klutchko
  • Patent number: 5162527
    Abstract: The invention concerns novel renin-inhibitory peptides which are useful for treating renin-associated hypertension, congestive heart failure, hyperaldosteronism and diseases caused by retroviruses including HTLV-I and -III. Processes for preparing the peptides, novel intermediates useful in the preparation thereof, compositions containing them, and methods of using them are included. Also included is a diagnostic method which uses the compounds to determine the presence of renin-associated hypertension, congestive heart failure, or hyperaldosteronism.
    Type: Grant
    Filed: March 27, 1991
    Date of Patent: November 10, 1992
    Assignee: Warner-Lambert Company
    Inventors: Annette M. Doherty, Harriet W. Hamilton, John C. Hodges, Joseph T. Repine, Ila Sircar
  • Patent number: 5135031
    Abstract: A rotary hydraulic machine which includes a housing having a shaft mounted for rotation within the housing about a shaft axis. A cylinder block is coupled to the shaft for co-rotation with the shaft within the housing and includes a plurality of cylinders disposed in a circumferential array parallel to and surrounding the shaft axis. A piston is disposed to reciprocate within each of the cylinders and is coupled to a yoke for determining displacement of the pistons within the cylinders. A valve plate is mounted on a valve block and includes kidney-shaped slots for registering with the cylinders as the cylinder block rotates, and thereby connecting the cylinders to pump input and output ports. A microprocessor-based controller is externally mounted on the pump valve block and includes internal memory having various remotely-selectable control programs prestored therein.
    Type: Grant
    Filed: September 30, 1991
    Date of Patent: August 4, 1992
    Assignee: Vickers, Incorporated
    Inventors: Roy T. Burgess, Rajamouli Gunda, Frank Herta, Robert C. Hodges, James A. Kessler, Richard S. Leemhuis, Michael R. McCarty, Robert W. Stephens